Patents by Inventor Jonathan P. Stoehr

Jonathan P. Stoehr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110287084
    Abstract: It is disclosed here that inhibiting the activity of the enzyme stearoyl-CoA desaturase (SCD1) in an animal causes the animal to have less body fat and greater lean body mass. The lower of SCD1 activity level can be accomplished by inhibiting activity of the enzyme or lowering levels of active enzyme in the subject.
    Type: Application
    Filed: April 28, 2011
    Publication date: November 24, 2011
    Inventors: James M. Ntambi, Alan D. Attie, Makoto Miyazaki, Jonathan P. Stoehr
  • Publication number: 20090221677
    Abstract: It is disclosed here that inhibiting the activity of the enzyme stearoyl-CoA desaturase (SCD1) in an animal causes the animal to have less body fat and greater lean body mass. The lower of SCD1 activity level can be accomplished by inhibiting activity of the enzyme or lowering levels of active enzyme in the subject.
    Type: Application
    Filed: March 17, 2009
    Publication date: September 3, 2009
    Inventors: James M. Ntambi, Alan D. Attie, Makoto Miyazaki, Jonathan P. Stoehr
  • Publication number: 20040115702
    Abstract: Two of the genetic bases for susceptibility to type 2 diabetes are disclosed. The alleles of the genes SorCS1 and SorCS3 that a person carries can determine whether or not that person is susceptible to type 2 diabetes.
    Type: Application
    Filed: September 5, 2003
    Publication date: June 17, 2004
    Inventors: Alan D. Attie, Jonathan P. Stoehr, Kathryn L. Schueler, Susanne Michelle Clee
  • Publication number: 20030064950
    Abstract: It is disclosed here that inhibiting the activity of the enzyme stearoyl-CoA desaturase (SCD1) in an animal causes the animal to have less body fat and greater lean body mass. The lower of SCD1 activity level can be accomplished by inhibiting activity of the enzyme or lowering levels of active enzyme in the subject.
    Type: Application
    Filed: March 8, 2002
    Publication date: April 3, 2003
    Inventors: James M. Ntambi, Alan D. Attie, Makoto Miyazaki, Jonathan P. Stoehr